The Research Library

Protocols for the
curious laboratory.

A reference compendium of theoretical dosing frameworks, device calibration notes and compound profiles. Every figure on this page is provided as a research-context reference — not a clinical instruction, not a recommendation, not a prescription.

Please read first

This material is written for research environments only.

All compounds referenced are presented strictly for laboratory research and development. Nothing here constitutes medical advice, diagnosis, treatment or a recommendation for human use. Anyone reading these tables is expected to understand the regulatory framework that applies in their own jurisdiction.

Cartridge calibration

Every cartridge in this reference is described against a 300-unit / 3 ml total volume. Conversion ratios on this page assume that baseline. As an example: a 30 mg compound in 3 ml means 10 units corresponds to 1 mg; a 20 mg compound means 15 units corresponds to 1 mg.

Pen device behaviour

Pen devices are calibrated in units, not milligrams. One click equals one unit as displayed in the dosing window. Allow at least 20 seconds for the device to complete delivery. Rotate administration sites in any research protocol that involves repeated dosing.

Storage & handling

Cartridges should be stored refrigerated unless the compound label states otherwise. Allowing the cartridge to reach room temperature prior to administration can reduce site discomfort. Pre-injection wipes are sensible practice though not always strictly required on intact, healthy skin.

On reusing pen tips

Published research has examined the repeated use of insulin pen tips and reports that re-use of up to five administrations did not produce adverse outcomes at the site or meaningful disruption to dosing accuracy in the conditions studied. Original reference: pubmed.ncbi.nlm.nih.gov/15649570.

01 — Metabolic Signalling

Incretin & Appetite Regulation

Continuous-administration compounds investigated in long-horizon metabolic studies. Effects accumulate over months rather than weeks, so research protocols here are titration ladders, not cycles.

02 — Tissue & Regeneration

Repair, Recovery & Longevity

Regenerative-pathway compounds and copper-peptide signalling agents researched for soft tissue, skin and connective-tissue models.

03 — Composite Protocols

Synergy Blends

Multi-peptide formulations designed to stack complementary repair, regeneration and anti-inflammatory pathways in a single vial.

04 — Bioenergetics & Performance

Mitochondrial & Metabolic Performance

Compounds investigated for their role in cellular energy regulation, mitochondrial function and exercise-mimetic signalling.

05 — Endocrine Signalling

Growth Hormone & IGF-1 Pathways

Compounds investigated for their interaction with growth-hormone release patterns, IGF-1 signalling and downstream recovery pathways.

Engineering, not estimation

Every protocol begins with a verified vial.

The figures on this page are only useful when the compound in front of you matches the certificate of analysis behind it. Browse the Novix catalogue for pharmaceutical-grade references, each shipped with batch documentation.